We report two men with limbic encephalitis (LE) refractory to corticosteroids, IVIg and plasma exchange. Both patients had serum/CSF antibodies that reacted with the cytoplasm of neurons. Probing of a hippocampal cDNA library resulted in the isolation of adenylate kinase 5 (AK5). Patients' antibodies, but not those of 111 controls, recognized AK5-expressing phage plaques. Human AK5-affinity purified antibodies reproduced the neuronal immunolabeling of patients' antibodies, and co-localized with a rabbit AK5 antibody, confirming that the brain autoantigen was AK5. Detection of antibodies to AK5 in LE patients carries a poor prognosis, and suggests the prompt use of aggressive immunosuppression.
Introduction
Clinical experience suggests that non-viral immune-mediated limbic encephalitis (LE) occurs more frequently than previously thought. Recognition of this disorder has been facilitated by improved neuroimaging techniques and the discovery of several autoantibodies that are used in diagnostic tests (Bataller and Dalmau, 2006) . Yet in about 20% of patients with clinical, MRI, and cerebrospinal fluid (CSF) findings compatible with immune-mediated LE, studies for all known autoantibodies are negative (Bataller et al., 2007) . We have investigated two LE patients whose syndrome had a relentless progression to dementia despite treatment with corticosteroids, intravenous immunoglobulin (IVIg), and plasma exchange. Both had antibodies to previously unknown neuronal antigens, which were characterized as adenylate kinase 5 (AK5).
Patient 1
A 71 year-old man developed rapidly progressive memory deficits, delusional thoughts, confusion, agitation and aggressive behavior. The neurological examination did not reveal focal deficits. The CSF showed no cells, normal protein (46 mg/dl) and glucose (58 mg/dl), increased IgG index (0.7) and positive oligoclonal bands. EEG was normal and the brain MRI demonstrated T2 and FLAIR hyperintensities in the right medial temporal lobe with mild contrast enhancement. CT of the chest, abdomen and pelvis, and body [18F]Fluorodeoxyglucose PET (FDG-PET) was normal. Testing for paraneoplastic and voltagegated potassium channels (VGKC) was negative. Treatment with corticosteroids, IVIg, and plasma exchange was not effective. The behavioral symptoms mildly improved with risperidone, but the memory deficits and cognitive dysfunction continued to progress. At follow-up 13 months after symptom presentation, he was severely demented and there was no evidence of cancer.
Patient 2
This 72 year-old man presented in January 2006 with rapidly progressive confusion, personality change and difficulty 
